
    
      Study will be carried on children patients with Î²- thalassemia major attending The Hematology
      Unit of Pediatric Department at Tanta University Hospital. patients are divided into 2
      groups: patients in the control group, patients in the treatment group that will receive
      nigella sativa powder for 3 consecutive months. Then Evaluate the therapeutic effects health
      benefits, and immunological effect of Nigella sativa in children with beta thalassemia major.

      Evaluate the extent of clinical improvement, reductions in serum iron and ferritin,
      antioxidant status, treatment of the causes of hemolysis and other therapeutic benefits of
      Nigella sativa in those patient.
    
  